Cardiologist and Physician Lead of the Heart Function Clinic Kingston Health Sciences Centre Queen's University
Disclosure(s):
Aws Almufleh, MBBS, MPH, FRCPC: Bayer: Consultant/Advisory Board (Ongoing); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Servier: Consultant/Advisory Board (Terminated, September 20, 2022)
Learning Objectives / Objectifs d'apprentissage:
At the end of this session participants will be able to / Au terme de cette conférence, vous serez:
discuss the trajectory of the future HF clinical care burden (Professional);
recognize short-term and long-term system solutions to the HF provider crisis (Health Advocate);
identify the recognized subspecialties and allied health disciplines within HF practice (Collaborator); and
propose training solutions and team to the HF provider crisis (Leader).
4 talks will highlight the looming HF provider crisis from the perspective of interdisciplinary team members. Each talk will include 1 polling question for interactivity. The session will conclude with a roundtable panel discussion of existing and potential North American solutions to meet the upcoming HF care requirements.
